• 1
    Cussons, A.J., Stuckey, B.G.A., Walsh, J.P., Burke, V. & Norman, R.J. (2005) Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clinical Endocrinology, 62, 289295.
  • 2
    Stein, I.F. & Leventhal, M.L. (1935) Amenorrhoea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology, 29, 181191.
  • 3
    The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. (revised 2003) Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 4147.
  • 4
    Azziz, R. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. Journal of Clinical Endocrinology and Metabolism, 91, 781785.
  • 5
    Franks, S. (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of Clinical Endocrinology and Metabolism, 91, 786789.
  • 6
    Belosi, C., Selvaggi, L., Apa, R., Guido, M., Romualdi, D., Fulghesu, A.M. & Lanzone, A. (2006) Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma. Human Reproduction, 21, 31083115.
  • 7
    Balen, A.H. & Michelmore, K. (2002) What is polycystic ovary syndrome? Are national views important? Human Reproduction, 17, 22192227.
  • 8
    Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H.F., Futterweit, W., Janssen, O.E., Legro, R.S., Norman, R.J., Taylor, A.E. & Witchel, S.F. (2006) Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism, 91, 42374245.
  • 9
    Goulden, V., Stables, G.I. & Cunliffe, W.J. (1999) Prevalence of facial acne in adults. Journal of the American Academy of Dermatology, 41, 577580.
  • 10
    Rushton, H., Lyons, G.M., Firth, P.S., Abrahams, R. & James, K.C. (1986) Scalp hair, facial skin and pregnancy. Journal of Obstetrics and Gynaecology, 7, 5152.
  • 11
    Welt, C.K., Gudmundsson, J.A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G. & Ingadottir, Crowley, W.F. (2006) Characterising discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. Journal of Clinical Endocrinology and Metabolism, 91, 48424848.
  • 12
    Ferriman, D. & Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology, 21, 14401447.
  • 13
    DeUgarte, C.M., Woods, K.S., Bartolucci, A.A. & Azziz, R. (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a population definition of hirsutism. Journal of Clinical Endocrinology and Metabolism, 91, 13451350.
  • 14
    British Institute and Association of Electrolysis. (accessed 26 February 2007).
  • 15
    Barth, J.H. (1997) How hairy are hirsute women? Clinical Endocrinology, 47, 255260.
  • 16
    Lunde, O. & Grottum, P. (1984) Body hair growth in women: normal or hirsute. American Journal of Physical Anthropology, 64, 307313.
  • 17
    Barth, J.H., Catalan, J., Cherry, C.A. & Day, A.E. (1993) Psychological morbidity in women referred for treatment of hirsutism. Journal of Psychosomatic Research, 37, 615619.
  • 18
    Shah, P.N. (1957) Human body hair – a quantitative study. American Journal of Obstetrics and Gynecology, 73, 12551265.
  • 19
    Barth, J.H., Cherry, C.A., Wojnarowska, F. & Dawber, R.P.R. (1991) Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study. Clinical Endocrinology, 35, 510.
  • 20
    Barth, J.H. (1996) How robust is the methodology for trials of therapy in hirsute women? Clinical Endocrinology, 45, 379380.
  • 21
    Wild, R.A., Vesely, S., Beebe, L., Whitsett, T. & Owen, W. (2005) Ferriman Gallwey self-scoring 1: performance assessment in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 90, 41124114.
  • 22
    Gibson, J.R., Harvey, S.G., Barth, J.H., Darley, C.R., Reshad, H.R. & Burke, C.A. (1984) Assessing inflammatory acne vulgaris: correlation between clinical and photographic methods. British Journal of Dermatology, 111 (Suppl. 27), 168170.
  • 23
    De Villez, R.L. & Dunn, J. (1986) Female androgenic alopecia: the 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness. Archives of Dermatology, 122, 10111015.
  • 24
    Rushton, D.H., Ramsay, I.D., James, K.C., Norris, M.J. & Gilkes, J.J. (1990) Biochemical and trichological characterization of diffuse alopecia in women. British Journal of Dermatology, 123, 187197.
  • 25
    Cela, E., Robertson, C., Rush, K., Kousta, E., White, D.M., Wilson, H., Lyons, G., Kingsley, P., McCarthy, M.I. & Franks, S. (2003) Prevalence of polycystic ovaries in women with androgenic alopecia. European Journal of Endocrinology, 149, 439442.
  • 26
    Ludwig, E. (1977) Classification of the types of androgenic alopecia (common baldness) arising in the female sex. British Journal of Dermatology, 97, 247254.
  • 27
    Norwood, O.T.T. (1975) Male pattern baldness: classification and incidence. Southern Medical Journal, 68, 13591365.
  • 28
    Venning, V.A. & Dawber, R.P.R. (1988) Patterned androgenic alopecia. Journal of the American Academy of Dermatology, 18, 10731078.
  • 29
    Rosner, W., Auchus, R.J., Azziz, R., Sluss, P.M. & Raff, H. (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405413.
  • 30
    Warner, M.H., Kane, J.W., Atkin, S.L. & Kilpatrick, E.S. (2006) Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Annals of Clinical Biochemistry, 43, 196199.
  • 31
    Jayagopal, V., Kilpatrick, E.S., Jennings, P.E., Hepburn, D.A. & Atkin, S.L. (2003) The biological variation of testosterone and sex hormone binding globulin (SHBG) in polycystic vary syndrome: implications for SHBG as a surrogate marker of insulin resistance. Journal of Clinical Endocrinology and Metabolism, 88, 15281533.
  • 32
    Cawood, M.L., Field, H.P., Ford, C.G., Gillingwater, S., Kicman, A., Cowan, D. & Barth, J.H. (2005) Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practise. Clinical Chemistry, 51, 14721479.
  • 33
    Gilling-Smith, C., Story, H., Rogers, V. & Franks, S. (1997) Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clinical Endocrinology, 47, 9399.
  • 34
    Fauser, B.C.J.M., Pache, T.D., Hop, W.C.J., De Jong, F.H. & Dahl, K.D. (1992) The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates. Clinical Endocrinology, 37, 445452.
  • 35
    Escobar-Morreale, H.F., Asuncion, M., Calvo, R.M., Sancho, J. & San Millan, J.L. (2001) Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. European Journal of Endocrinology, 145, 619624.
  • 36
    Knochenhauer, E.S., Key, T.J., Kahsar-Miller, M., Waggoner, W., Boots, L.R. & Azziz, R. (1988) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism, 83, 30783082.
  • 37
    Middle, J.G. & UK NEQAS. (2006) Steroid Hormones Annual Review for Progesterone. (Available from the author at UK NEQAS, PO Box 3909, Birmingham B15 2UE, UK).
  • 38
    Balen, A.H., Laven, J.S.E., Tan, S.L. & Dewailly, D. (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update, 9, 505514.
  • 39
    Jonard, S., Robert, Y. & Dewailly, D. (2005) Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries? Human Reproduction, 20, 28932898.
  • 40
    Allemand, M., Tummon, I.S., Phy, J.L., Foong, S.C., Dumesic, D.A. & Session, D.R. (2006) Diagnosis of polycystic ovaries by three dimensional transvaginal ultrasound. Fertility and Sterility, 85, 214219.
  • 41
    Amer, S.A.K.S., Li, T.C., Bygrave, C., Sprigg, A., Sravelos, H. & Cooke, I.D. (2002) An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries. Human Reproduction, 17, 16161622.
  • 42
    Jayagopal, V., Kilpatrick, E.S., Holding, S., Jennings, P.E. & Atkin, S.L. (2002) The biological variation of insulin resistance in polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 15601562.
  • 43
    Marcovina, S., Bowsher, R.R., Miller, W.G., Staten, M., Myers, G., Caudill, S.P., Campbell, S.E. & Steffes, M.W. for the Insulin Standardization Workgroup (2007) Standardization of insulin immunoassays: report of the American Diabetes Association workgroup. Clinical Chemistry, 53, 711716.
  • 44
    Rickenlund, A., Thoren, M., Carlstrom, K., Von Schoultz, B. & Hirschberg, A.L. (2004) Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. Journal of Clinical Endocrinology and Metabolism, 89, 702707.
  • 45
    Garde, A.H., Hansen, A.M., Skovgaard, L.T. & Christensen, J.M. (2000) Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A (1c), IgA, prolactin, and free testosterone in healthy women. Clinical Chemistry, 46, 551559.
  • 46
    Azziz, R., Bradley, E. Jr, Huth, J., Boots, L.R., Parker, C.R. Jr & Zacur, H.A. (1990) Acute adrenocorticotropin-(1–24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time. Journal of Clinical Endocrinology and Metabolism, 70, 12731279.
  • 47
    Massafra, C., De Felice, C., Agnusdei, D.P., Gioia, D. & Bagnoli, F. (1999) Androgens and osteocalcin during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 84, 971974.
  • 48
    Maes, M., Mommen, K., Hendrickx, D., Peeters, D., D’Hondt, P., Ranjan, R., De Meyer, F. & Scharpe, S. (1997) Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clinical Endocrinology, 46, 587598.
  • 49
    Winters, S.J., Talbott, E., Guzick, D.S., Zborowski, J. & McHugh, K.P. (2000) Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertility and Sterility, 73, 724729.
  • 50
    Zumoff, B., Strain, G.W., Miller, L.K. & Rosner, W. (1995) Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. Journal of Clinical Endocrinology and Metabolism, 80, 14291430.
  • 51
    Torjesen, P.A. & Bjoro, T. (1996) Antibodies against [125I] testosterone in patient's serum: a problem for the laboratory and the patient. Clinical Chemistry, 42, 20472048.